Beau Jason Caruthers , ARNP
Nurse Practitioner • Ocala, FL
1740 Se 18th St, Suite 1002
Ocala, FL 344715408
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on December 20, 2012; this date does not establish years in practice.
-
Published CMS data list 2,514 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 95004 — Test for allergy using allergenic extract: 1,602 service units.
- 99214 — Established patient outpatient office visit: 299 service units.
- 99213 — Established patient outpatient office visit: 166 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 973 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Montelukast Sodium — 142 prescription fills, including refills.
- Levocetirizine Dihydrochloride — 95 prescription fills, including refills.
- Fluticasone Propionate — 88 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Nurse Practitioner in Ocala, FL (2024, 54 clinicians with data). Median for this group: 435. Middle half: 97 to 1,081.
More Medicare Part B services than 90% of clinicians listed under Nurse Practitioner in Florida (2024, 3,093 clinicians with data). Median for this group: 281. Middle half: 98 to 758.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 4,635 in 2023 to 2,514 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023–2024.
Practice Location & Contact Primary Location
1740 Se 18th St
Suite 1002
Ocala, FL 344715408
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
425 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $61,329 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $41,583 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,970 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$332,952 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $240.92 across 10 records.
By nature of payment
- Food and Beverage: $240.92 across 10 records.
Reporting-company totals (3 largest of 8)
- AstraZeneca Pharmaceuticals LP: $44.16 across 2 records.
- Pfizer Inc.: $36.16 across 2 records.
- BioCryst Pharmaceuticals, Inc.: $33.43 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2012
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Beau Caruthers has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Beau Caruthers as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Ocala and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Nurse Practitioner in Ocala, FL (2024, 54 clinicians with data). Median for this group: 435. Middle half: 97 to 1,081.
More Medicare Part B services than 90% of clinicians listed under Nurse Practitioner in Florida (2024, 3,093 clinicians with data). Median for this group: 281. Middle half: 98 to 758.
Medicare-allowed amount
A higher Medicare-allowed amount than 65% of clinicians listed under Nurse Practitioner in Ocala, FL (2024, 54 clinicians with data). Median for this group: $37,169. Middle half: $11,647 to $82,147.
A higher Medicare-allowed amount than 75% of clinicians listed under Nurse Practitioner in Florida (2024, 3,093 clinicians with data). Median for this group: $22,890. Middle half: $8,465 to $56,388.
Paid by Medicare
A higher Medicare payment amount than 65% of clinicians listed under Nurse Practitioner in Ocala, FL (2024, 54 clinicians with data). Median for this group: $27,587. Middle half: $9,247 to $64,303.
A higher Medicare payment amount than 70% of clinicians listed under Nurse Practitioner in Florida (2024, 3,093 clinicians with data). Median for this group: $17,374. Middle half: $6,293 to $42,181.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner in Ocala, FL (2024, 57 clinicians with data). Median for this group: 353. Middle half: 84 to 1,484.
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: 306. Middle half: 76 to 1,100.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Nurse Practitioner in Ocala, FL (2024, 57 clinicians with data). Median for this group: $19,449. Middle half: $1,691 to $156,012.
A higher Part D drug cost than 85% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: $18,227. Middle half: $1,370 to $130,581.
125 active clinicians are listed under Nurse Practitioner with a practice address in Ocala, FL (8,853 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Ocala
5.6% of these 125 clinicians have the CMS telehealth indicator.
52.8% of these 125 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 46% from 4,635 in 2023 to 2,514 in 2024.
- 2023: 4,635
- 2024: 2,514
-
Medicare-allowed amount
Medicare-allowed amount decreased 58% from $146,455 in 2023 to $61,329 in 2024.
- 2023: $146,455
- 2024: $61,329
-
Paid by Medicare
Paid by Medicare decreased 63% from $113,401 in 2023 to $41,583 in 2024.
- 2023: $113,401
- 2024: $41,583
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 22% from 1,240 in 2020 to 973 in 2024.
- 2020: 1,240
- 2021: 1,379
- 2022: 1,540
- 2023: 1,716
- 2024: 973
-
30-day fills
30-day fills decreased 15% from 2,306 in 2020 to 1,970 in 2024.
- 2020: 2,306
- 2021: 2,676
- 2022: 3,055
- 2023: 3,375
- 2024: 1,970
-
Part D drug cost
Part D drug cost increased 10% from $303,903 in 2020 to $332,952 in 2024.
- 2020: $303,903
- 2021: $403,232
- 2022: $451,441
- 2023: $665,384
- 2024: $332,952
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 89% from $2,122.57 in 2021 to $240.92 in 2025.
- 2021: $2,122.57
- 2022: $2,316.24
- 2023: $1,730.04
- 2024: $2,124.91
- 2025: $240.92
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $240.92.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| BioCryst Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ORLADEYO | General | $33.43 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.99 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $28.02 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $26.66 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $25.80 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $21.42 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $19.94 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
OCTAGAM IMMUNE GLOBULIN (HUMAN) | General | $18.70 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $17.50 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CIBINQO | General | $17.46 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2022–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2023–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
95004
Test for allergy using allergenic extract
|
1,602 | 26 | $12.00 | $3.04 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
299 | 235 | $281.43 | $105.73 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
166 | 139 | $192.63 | $74.89 |
|
95115
Professional service for single injection of allergen
|
106 | 18 | $27.00 | $8.26 |
|
94010
Test to measure expiratory airflow and volume
|
90 | 81 | $65.05 | $21.97 |
|
96160
Administration and interpretation of patient-focused health risk assessment
|
82 | 75 | $40.73 | $2.36 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
56 | 56 | $255.32 | $92.47 |
|
95117
Professional service for multiple injections of allergen
|
45 | 17 | $31.67 | $9.81 |
|
96372
Injection of drug or substance under skin or into muscle
|
29 | 15 | $45.00 | $11.54 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
23 | 23 | $381.21 | $138.86 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
16 | 16 | $40.13 | $13.68 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Montelukast Sodium | Montelukast Sodium | 142 | 11,851 | $2,175.71 | 64 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 95 | 7,880 | $1,672.37 | 39 |
| Fluticasone Propionate | Fluticasone Propionate | 88 | 6,230 | $2,166.47 | 46 |
| Azelastine Hcl | Azelastine Hcl | 75 | 4,617 | $3,652.98 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 73 | 2,423 | $2,723.83 | 48 |
| Breo Ellipta | Fluticasone/Vilanterol | 66 | 3,630 | $46,611.40 | 18 |
| Ipratropium Bromide | Ipratropium Bromide | 65 | 2,955 | $2,628.99 | 29 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 54 | 2,910 | $59,050.96 | 20 |
| Symbicort | Budesonide/Formoterol Fumarate | 53 | 3,060 | $22,559.76 | 19 |
| Epinephrine | Epinephrine | 48 | 1,124 | $9,405.60 | 44 |
| Spiriva Respimat | Tiotropium Bromide | 38 | 1,830 | $31,675.89 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | 2,580 | $6,728.42 | 17 |
| Arnuity Ellipta | Fluticasone Furoate | 22 | 1,290 | $8,528.33 | — |
| Dupixent Syringe | Dupilumab | 19 | 644 | $108,917.18 | — |
| Ventolin Hfa | Albuterol Sulfate | 17 | 459 | $1,202.50 | 13 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | 750 | $4,548.90 | — |
| Dulera | Mometasone/Formoterol | 15 | 510 | $5,527.89 | — |
| Qvar Redihaler | Beclomethasone Dipropionate | 15 | 780 | $5,487.39 | — |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | 1,110 | $4,700.16 | — |
| Prednisone | Prednisone | 11 | 55 | $18.64 | 11 |
| Alvesco | Ciclesonide | 11 | 338 | $2,968.69 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20130124000331
FL
0042464133
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Allergy & Immunology
Doctor of Medicine (M.D.)
Allergy & Immunology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated December 20, 2012.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Nurse Practitioners in Ocala
- Melissa Lozano
- Kristina Mccormick, ARNP
- Joy Hall, ARNP
- Amber Vanrijk, NP-C
- Shekeita Perry, APRN
- Rebecca Long, ARNP
Mailing Address
1740 Se 18th St, Suite 1002
Ocala, FL 344715408
Phone: 3526221126